Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma-Reference-Cited by-同舟云学术

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

Published:2011-04-12 Issue:3 Volume:14 Page:255-266
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Patterson Danielle M.,Gao Dongbing,Trahan Denae N.,Johnson Brett A.,Ludwig Andrew,Barbieri Eveline,Chen Zaowen,Diaz-Miron Jose,Vassilev Lyubomir,Shohet Jason M.,Kim Eugene S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-011-9210-8.pdf

Reference52 articles.

1. Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B (2005) Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol 6(9):649–658. doi: 10.1016/S1470-2045(05)70291-6

2. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 341(16):1165–1173

3. Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML (2007) Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the children’s oncology group. Pediatrics 120(5):e1229–e1236. doi: 10.1542/peds.2007-0178

4. Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, Cheung NK (2009) Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatr Blood Cancer 53(1):17–22. doi: 10.1002/pbc.21931

5. Laverdiere C, Cheung NK, Kushner BH, Kramer K, Modak S, LaQuaglia MP, Wolden S, Ness KK, Gurney JG, Sklar CA (2005) Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 45(3):324–332. doi: 10.1002/pbc.20331

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of MDM2 in angiogenesis: implications for endothelial tip cell formation;In Vitro Cellular & Developmental Biology - Animal;2024-08-12

2. Association of Vascular Endothelial Growth Factor (VEGF) and Mouse Model Minute 2 (MDM2) Polymorphisms With Diabetic Retinopathy in a Northwest Indian Population: A Case-Control Study;Cureus;2024-06-23

3. Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis;Molecular Cancer Therapeutics;2024-04-26

4. Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy;Journal of Biomedical Science;2024-01-29

5. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells;Comprehensive Hematology and Stem Cell Research;2024